Post hoc comparisons using Tukey HSD test showed that expression levels of GPX4, xCT, and FTH1 were significantly reduced in MCAO compared to the Sham and Sham+CSO groups, and CSO treatment restored the expression of those proteins in the MCAO+CSO group. The gene discussed is FTH1; the disease is craniosynostosis.